![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-601d89938ef8ff18f7fd29232430c0bc957dbaf67f71e420d1bcf900a218cabe.jpg)
ravulizumab
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.